Cytosorbents Corporation operates within the Surgical and medical instruments sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Cytosorbents with three other
companies in this sector in UNITED STATES :
Utah Medical Products, Inc.
sales of $42.18 million
of which 49%
Akoya Biosciences Inc
of which 56%
was Instruments), and
Aziyo Biologics Inc
of which 100%
During the second
quarter of 2021, sales at Cytosorbents totalled
an increase of 22.8%
from the $9.79 million in sales at the company during the second quarter of 2020.
During the first two
quarters of 2021, sales totalled $22.62 million, which is
than through the first two quarters of 2020.
During the previous 24 quarters, sales at Cytosorbents have increased compared with the same quarter in the previous year.
During the year ended December of 2020, sales at
Cytosorbents were $41.00 million.
increase of 64.4%
versus 2019, when the company's sales were $24.95 million.
This was the fifth consecutive year of sales increases at Cytosorbents
(and since 2015, sales have increased a total of 756%).